KMD Bioscience has extensive experience in protein expression research and possesses profound expertise in viral vector development. The company has established a comprehensive lentiviral packaging technology platform, providing end-to-end technical services encompassing vector design, viral packaging, purification processes, and transduction validation. Building upon its lentiviral packaging system, KMD Bioscience employs high-titer production processes and stringent quality control assays to ensure optimal technical parameters such as viral titer and cytotoxicity from the outset. This approach guarantees lentiviral vectors exhibit high infectivity, low cytotoxicity, and batch-to-batch stability, thereby reducing overall experimental costs while maximizing protection for precious primary cells or stem cell samples, thereby safeguarding clients' research endeavors.
KMD Bioscience‘s technology employs second-and third-generation self-inactivating lentiviral infection vector systems to achieve lentiviral packaging for human cells (e.g., HEK293T, HUVEC), animal cells (e.g., primary mouse neurons, rat cardiomyocytes), and difficult-to-transfect cells (e.g., primary T cells, stem cells). Each batch of viruses undergoes titration testing, sterility assessment, mycoplasma detection, and insertion fragment validation, ensuring viral safety, efficacy, and accurate expression of the target gene, thereby providing a solid foundation for your scientific research.
0
